BRPI1009752A2 - Sistema de vetor de expressão comprendendo dois marcadores de seleção - Google Patents

Sistema de vetor de expressão comprendendo dois marcadores de seleção

Info

Publication number
BRPI1009752A2
BRPI1009752A2 BRPI1009752-0A BRPI1009752A BRPI1009752A2 BR PI1009752 A2 BRPI1009752 A2 BR PI1009752A2 BR PI1009752 A BRPI1009752 A BR PI1009752A BR PI1009752 A2 BRPI1009752 A2 BR PI1009752A2
Authority
BR
Brazil
Prior art keywords
expression vector
vector system
selection markers
markers
selection
Prior art date
Application number
BRPI1009752-0A
Other languages
English (en)
Inventor
Thomas Jostock
Hans-Peter Knopf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI1009752A2 publication Critical patent/BRPI1009752A2/pt
Publication of BRPI1009752B1 publication Critical patent/BRPI1009752B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003Dihydrofolate reductase [DHFR] (1.5.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y105/00Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C12Y105/01003Dihydrofolate reductase (1.5.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/40Systems of functionally co-operating vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1009752-0A 2009-02-27 2010-02-26 Vetor de expressão ou uma combinação de pelo menos dois vetores de expressão e métodos para sua produção e sua seleção, bem como processo para produzir um produto de interesse e uso de um meio de cultura seletivo BRPI1009752B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09153995.7 2009-02-27
EP09153995 2009-02-27
PCT/EP2010/001224 WO2010097240A1 (en) 2009-02-27 2010-02-26 Expression vector system comprising two selection markers

Publications (2)

Publication Number Publication Date
BRPI1009752A2 true BRPI1009752A2 (pt) 2015-08-25
BRPI1009752B1 BRPI1009752B1 (pt) 2020-03-10

Family

ID=40886421

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009752-0A BRPI1009752B1 (pt) 2009-02-27 2010-02-26 Vetor de expressão ou uma combinação de pelo menos dois vetores de expressão e métodos para sua produção e sua seleção, bem como processo para produzir um produto de interesse e uso de um meio de cultura seletivo

Country Status (16)

Country Link
US (3) US9534226B2 (pt)
EP (1) EP2401377B1 (pt)
JP (2) JP5801207B2 (pt)
KR (1) KR101707251B1 (pt)
CN (1) CN102333871B (pt)
BR (1) BRPI1009752B1 (pt)
CA (1) CA2753814C (pt)
DK (1) DK2401377T3 (pt)
ES (1) ES2587630T3 (pt)
IL (1) IL214621A (pt)
MX (1) MX2011009025A (pt)
PL (1) PL2401377T3 (pt)
PT (1) PT2401377T (pt)
RU (2) RU2535986C2 (pt)
SG (1) SG173456A1 (pt)
WO (1) WO2010097240A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2401377T (pt) 2009-02-27 2016-08-18 Novartis Ag Sistema de vectores de expressão compreendendo dois marcadores de selecção
JP5913122B2 (ja) * 2010-11-08 2016-04-27 Jcrファーマ株式会社 新規発現ベクター
SG11201503326PA (en) 2012-11-20 2015-06-29 Novartis Ag Optimized expression cassette for expressing a polypeptide with high yield
US20160017319A1 (en) 2013-03-11 2016-01-21 Audrey Nommay Method of screening cell clones
RU2716977C2 (ru) * 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев
AU2014369177B2 (en) 2013-12-20 2017-04-20 Novartis Ag Novel eukaryotic cells and methods for recombinantly expressing a product of interest
EP3604331A1 (en) 2013-12-20 2020-02-05 Novartis AG Novel eukaryotic cells and methods for recombinantly expressing a product of interest
MX368664B (es) 2014-04-29 2019-10-10 Novartis Ag Células novedosas de vertebrados y métodos para la expresión recombinante de un polipéptido de interés.
KR102622657B1 (ko) * 2015-04-03 2024-01-10 셀렉시스 에스. 에이. 포유류 세포에서 재조합 단백질 생산을 위한 비타민 및 비타민 대사 유전자 및 단백질의 용도
UY37758A (es) * 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
EP3692153A1 (en) 2017-10-02 2020-08-12 Astrazeneca AB Cell lines and methods for increased protein production
CN111511759B (zh) * 2017-10-12 2024-07-30 杰克逊实验室 转基因选择方法和组合物
TWI818166B (zh) * 2019-03-27 2023-10-11 美商菲尼克斯組織修復公司 用於生產膠原蛋白7組合物之系統及方法
CN116615655A (zh) * 2020-11-19 2023-08-18 建新公司 流式细胞术减弱报告物表达(flare)多种报告物系统及其使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE199023T1 (de) 1991-03-29 2001-02-15 Genentech Inc Methoden zur selektion von rekombinanten wirtszellen welche hohe mengen von einem gewünschten protein exprimieren
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5830698A (en) * 1997-03-14 1998-11-03 Idec Pharmaceuticals Corporation Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
DE10036491A1 (de) * 2000-07-25 2002-02-07 Roche Diagnostics Gmbh Expression von Alkalischer Phosphatase in Hefe
DE10256083A1 (de) 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
PT1601776E (pt) 2003-03-11 2008-09-17 Serono Lab Vectores de expressão que compreendem o promotor ie2 do mcmv
TW200513351A (en) * 2003-07-17 2005-04-16 Availvs Corp High pressure water jet surface cutting device and cutting method
EP1716233B1 (en) 2004-01-30 2009-08-26 Maxygen Holdings Ltd. Regulated stop codon readthrough
IL165484A0 (en) * 2004-11-30 2006-01-15 Applied Research Systems Production of proteins
CN101389763B (zh) 2006-02-21 2013-01-23 科罗迈吉尼科斯公司 高水平表达蛋白质的宿主细胞的选择
ES2573027T3 (es) 2006-05-17 2016-06-03 F. Hoffmann-La Roche Ag Células productoras de polipéptido
PT2227549E (pt) 2007-12-21 2015-10-08 Novartis Ag Sistema de seleção para cultura de células eucarióticas com base num gene de recetor de folato ligado à membrana
KR101734585B1 (ko) 2008-08-28 2017-05-11 노파르티스 아게 정지 코돈 번역초과에 의한 폴리펩티드 이소형의 세포 표면 표시
PT2401377T (pt) 2009-02-27 2016-08-18 Novartis Ag Sistema de vectores de expressão compreendendo dois marcadores de selecção
DK2401383T3 (da) 2009-02-27 2013-12-16 Novartis Ag Fremgangsmåder til udvælgelse af eukaryote celler, som udtrykker et heterologt protein
RU2716977C2 (ru) 2013-07-31 2020-03-17 Новартис Аг Новые селективные векторы и способы селекции эукариотических клеток-хозяев

Also Published As

Publication number Publication date
BRPI1009752B1 (pt) 2020-03-10
IL214621A (en) 2016-02-29
JP2015109839A (ja) 2015-06-18
MX2011009025A (es) 2011-09-28
PT2401377T (pt) 2016-08-18
SG173456A1 (en) 2011-09-29
CA2753814C (en) 2018-07-31
PL2401377T3 (pl) 2016-11-30
US9534226B2 (en) 2017-01-03
RU2014101759A (ru) 2015-08-10
AU2010219089A1 (en) 2011-08-18
KR20110119837A (ko) 2011-11-02
KR101707251B1 (ko) 2017-02-15
US20170067077A1 (en) 2017-03-09
CN102333871A (zh) 2012-01-25
WO2010097240A1 (en) 2010-09-02
US20180265891A1 (en) 2018-09-20
CA2753814A1 (en) 2010-09-02
DK2401377T3 (en) 2016-08-29
JP5801207B2 (ja) 2015-10-28
RU2649361C2 (ru) 2018-04-02
CN102333871B (zh) 2013-12-04
US11174494B2 (en) 2021-11-16
EP2401377B1 (en) 2016-05-18
IL214621A0 (en) 2011-09-27
ES2587630T3 (es) 2016-10-25
US20110306092A1 (en) 2011-12-15
US9994866B2 (en) 2018-06-12
RU2535986C2 (ru) 2014-12-20
EP2401377A1 (en) 2012-01-04
RU2011139182A (ru) 2013-04-10
JP2012518992A (ja) 2012-08-23

Similar Documents

Publication Publication Date Title
BRPI1009752A2 (pt) Sistema de vetor de expressão comprendendo dois marcadores de seleção
BRPI1014643A2 (pt) sistema de antenas distribuídas
BRPI1010217A2 (pt) sistema
EP2307902A4 (en) WIRELESS LOCATION SYSTEM
BRPI1010873A2 (pt) vetor genético
ES2864688T8 (es) Sistema de ablación
BR112013011964A2 (pt) sistema de navegação
BR112013007839A2 (pt) sistema de refrigeração
BRPI1012833A2 (pt) sistema de conexão de comunicação
BRPI1007799A2 (pt) sistema anti-erosão
BRPI0912054A2 (pt) sistema de posicionamento
BRPI0822520A2 (pt) Sistema de plasma
BR112013001593A2 (pt) ''sistema de distribuição''
BR112013021322A2 (pt) sistema de transferência de fluido
BR112013011835A2 (pt) sistema de compensação de deslocamento
BR112013011955A2 (pt) sistema de distribuição de anúncio
DK2482768T3 (da) Intrauterint system
IT1400794B1 (it) Sistema di iniezione
BRPI1014417A2 (pt) sistema
BRPI1006691A2 (pt) sistema
BR112012026166A2 (pt) sistema de cobertura
BRPI0922999A2 (pt) sistema submarino
BR112012003347A2 (pt) sistema
BR112012003179A2 (pt) sistema bio-eletrônico
BRPI1006688A2 (pt) sistema

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.